Skip to main content
SpringerLink
Log in

Bewegungsstörungen

  • Chapter
Klinische Neurologie

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 209.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zitierte Literatur

  • Adler CH (1992) Treatment of restless legs syndrome with Gabapentin. Clin Neuopharmacol 20: 148–151

    Google Scholar 

  • Alderson K, Holds JB, Anderson RL (1991) Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41: 1800–1805

    CAS  PubMed  Google Scholar 

  • Alesch F, Pinter MM, Helscher RJ et al. (1992) Stimulation of son’s disease. J Neurol Neurosurg Psychiatry 55: 566–571

    Google Scholar 

  • Allen RP, Picchietti D, Hening WA et al. (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4: 101–119

    PubMed  Google Scholar 

  • American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3. Aufl, korrigiert

    Google Scholar 

  • Aoki KR, Francis J, Hasanthi R, Leumer D (2003) Comparison of the therapeutic windows of different botulinum neurotoxin preparations in an animal model. 55th Academy of Neurology Meeting, P03.088

    Google Scholar 

  • Arya DK (1994) Extrapyramidal symptoms with selective serotonin reuptake inhibitors. Br J Psychiatry 165: 728–733

    CAS  PubMed  Google Scholar 

  • Ayd F (1961) A survey of drug induced induced extrapyra midal reactions. JAMA 175: 1054–1060

    CAS  PubMed  Google Scholar 

  • Baas H, Beiske AG, Chika J et al. (1997) Catechol-O-methyltransferase inhibi tion with tolcapone reduces the »wearing off« phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry 63: 421–428

    CAS  PubMed  Google Scholar 

  • Baas H, Deuschl D, Oertel W, Poewe W (1996) Medikamentöse Therapie der Parkinson-Krankheit. Dtsch Ärzteblatt 93: A-2470–2477

    Google Scholar 

  • Baas H, Beiske AG, Ghika J Poewe W et al. (1997) Catechol-O-methyltransferase inhibition with tolcapone reduces the »wearing off« phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry 63: 421–428

    CAS  PubMed  Google Scholar 

  • Bannister R, Mathias CJ (1992) Clinical features and investigation of the primary autonomic failure syndromes. In: Bannister R, Mathias CJ (eds) Autonomic failure. Oxford Univ Press, Oxford New York Tokyo, pp 531–547

    Google Scholar 

  • Barclay CL, Lang AE (1997) Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 62: 352–356

    CAS  PubMed  Google Scholar 

  • Barnes TRE, Brande WM (1985) Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 428: 874–878

    Google Scholar 

  • Becker PM, Jamieson AO, Brown WD (1993) Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: Response and complications of extended treatment in 49 cases. Sleep 16: 713–716

    CAS  PubMed  Google Scholar 

  • Benabid AL, Pollak P, Gervason C et al. (1991) Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337: 403–406

    Article  CAS  PubMed  Google Scholar 

  • Benecke R, Jost WH, Kanovsky P, Ruzicka E, Comes G, Grafe S (2005) A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology 64: 1949–1951

    CAS  PubMed  Google Scholar 

  • Bennett DA, Beckett LA, Murray AM et al. (1996) Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334: 71–76

    Article  CAS  PubMed  Google Scholar 

  • Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436–1438

    CAS  PubMed  Google Scholar 

  • Biggins CA, Boyd JL, Harrop FM et al. (1992) A controlled, longitudinal study of dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 55: 566–571

    CAS  PubMed  Google Scholar 

  • Black SE (1996) Focal cortical atrophy syndromes. Brain Cogn 31: 188–229

    CAS  PubMed  Google Scholar 

  • Bonuccelli U, Ceravolo R, Salvetti S et al. (1997) Clozapine in Parkinson’s disease tremor. Effects of acute and chronic administration. Neurology 49: 1587–1590

    CAS  PubMed  Google Scholar 

  • Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 49: 1284–1288

    CAS  PubMed  Google Scholar 

  • Brashear A, Lew MF, Dykstra DD et al. (1999) Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53: 1439–1446

    CAS  PubMed  Google Scholar 

  • Breidenbach MA, Brunger AT (2004) Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432: 925–929

    Article  CAS  PubMed  Google Scholar 

  • Brin MF, Lew MF, Adler CH et al. (1999) Safety and efficacy of Neuro Bloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53: 1431–1438

    CAS  PubMed  Google Scholar 

  • Burke RE, Fahn S, Jankovic J et al. (1982) Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 32: 1335–1346

    CAS  PubMed  Google Scholar 

  • Burke RE, Kang UJ, Jankovic J et al. (1989) Tardive akathisia: an analysis of clinical features and response to open thera peutic trials. Mov Disord 4: 157–175

    CAS  PubMed  Google Scholar 

  • Cardoso FE, Jankovic J (1993) Cocaine-related movement disorders. Mov Disord 8: 175–178

    Article  CAS  PubMed  Google Scholar 

  • Castelon Konkiewitz E, Trender-Gerhard I, Kamm C et al. (2002) Service-based survey of dystonia in Munich. Neuroepidemiology 21: 202–206

    Article  CAS  PubMed  Google Scholar 

  • Ceballos-Baumann AO (1994) Klinik und Therapie der Dystonien. Akt Neurol 21: 99–106

    Google Scholar 

  • Ceballos-Baumann AO (1996) Dystonien. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart New York, S 89–140

    Google Scholar 

  • Ceballos-Baumann AO (2001) Evidence-based medicine in botulinum toxin therapy for cervical dystonia. J Neurol 248(Suppl 1): 14–20

    PubMed  Google Scholar 

  • Ceballos-Baumann AO (2003) Die Rolle der EMG-Steuerung bei der Botulinumtoxin-Therapie. Klin Neurophysiol 34: 1–7

    Google Scholar 

  • Ceballos-Baumann AO, Konstanzer A, Dengler R, Conrad B (1990a) Lokale Injektionen von Botulinum-Toxin A bei zervikaler Dystonie: Verlaufsbeobachtungen an 45 Patienten. Akt Neurol 17: 139–145

    Google Scholar 

  • Ceballos-Baumann AO, Kummer R von, Eckert W, Weicker H (1990b) Controlled-release levodopa/benserazide (Madopar HBS): Clinical observations and levodopa and dopa mine plasma concentrations in fluctuating parkinsonian patients. J Neurol 237: 24–28

    Article  CAS  PubMed  Google Scholar 

  • Ceballos-Baumann AO, Böhme G, Konstanzer A et al. (1992) Spasmodische Dysphonie: Klinik und Erfahrungen mit laryngealen Injektionen von Botulinum-Toxin. Otorhinolaryngologia nova 2: 33–38

    Google Scholar 

  • Ceballos-Baumann AO, Obeso JA, Vitek JL et al. (1994) Restoration of thalamocortical activity following posteroventral pallidotomy in Parkinson’s disease. Lancet 344: 814–814

    CAS  PubMed  Google Scholar 

  • Ceballos-Baumann AO, Passingham RE, Marsden CD, Brooks DJ (1995a) Motor reorganisation in acquired hemidystonia: a PET activation study. Ann Neurol 37: 746–757

    CAS  PubMed  Google Scholar 

  • Ceballos-Baumann AO, Passingham RE, Warner T et al. (1995b) Overactivity of prefrontal and underactivity of motor cortical areas in idiopathic dystonia: a PET activa tion study. Ann Neurol 37: 363–372

    CAS  PubMed  Google Scholar 

  • Ceballos-Baumann AO, Beocker H, Bartenstein P et al. (1999) A PET study of subthalamic nucleus stimulation in Parkinson’s disease: Enhanced movement related activity of motor association cortex and decreased motor cortex resting activity. Arch Neurol (in press)

    Google Scholar 

  • Ceballos-Baumann AO, Sheean G, Passingham RE et al. (to be published) Botulinum toxin does not reverse the cortical dysfunction associated with writer’s cramp: a PET study. Brain

    Google Scholar 

  • Ceballos-Baumann AO, Kupsch A, Naumann M, Volkmann J (2002) Dystonie. In: http://www.dgn.org/leitl.shtml, Hrsg. Leitlinien der Deutschen Gesellschaft für Neurologie

    Google Scholar 

  • Coleman RM (1982) Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C (ed) Sleeping and waking disorders: indications and techniques. Addison-Wesley, Menlo-park, pp 265–295

    Google Scholar 

  • Comella C, Jankovic J, Leurgans S, Fan W, Chmura T, Group DS. Botulinum serotype A compared to B in cervical dystonia: Randomized, double-blind, parallel study

    Google Scholar 

  • Davis BJ, Rajput A, Rajput ML et al. (2000) A randomized doubleblind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 49: 70–75

    Google Scholar 

  • Deacon T, Schumacher J, Dinsmore J et al. (1997) Histological evidence of fetal pig neural cell survival after transplanta tion into a patient with parkinsons disease. Nat Med 3: 350–353

    Article  CAS  PubMed  Google Scholar 

  • Deep-Brain-Stimulation-Study-Group (2001) Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 345: 956–963

    Google Scholar 

  • Deuschl G, Köster B (1996) Diagnose und Behandlung des Tremors. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart, S 222–253

    Google Scholar 

  • Deuschl G, Toro C, Matsumoto J, Hallett M (1995) Movement related cortical potentials in writer’s cramp. Ann Neurol 38: 862–868

    Article  CAS  PubMed  Google Scholar 

  • Ehrenberg BL, Eisensehr I, Corbett KE et al. (2000) Valproate for sleep consolidation in periodic limits movement disorder. J Clin Psychopharmacol 20: 574–578

    Article  CAS  PubMed  Google Scholar 

  • Engel PA (1996) Treatment of progressive supranuclear palsy with amitriptyline: therapeutic and toxic effects. J Am Geriatr Soc 44: 1072–1074

    CAS  PubMed  Google Scholar 

  • Erbguth F, Benecke R, Ceballos-Baumann AO et al. (1995) Lokale Injektionsbehandlung fokaler Hyperkinesen mit Botulinum-Toxin A. Dtsch Ärzteblatt 92: B-2002–2008

    Google Scholar 

  • Fahn S, Bressman SB, Marsden CD (1998) Classification of dystonia. Adv Neurol 78: 1–10

    CAS  PubMed  Google Scholar 

  • Fleischhacker WW, Miller CH, Bergmann KJ (1989) Die neuroleptikainduzierte Akathisie. Nervenarzt 60: 719–723

    CAS  PubMed  Google Scholar 

  • Ford B, Greene P, Louis ED et al. (1996) Use of intrathecal bac lofen in the treatment of patients with dystonia. Arch Neurol 53: 1241–1246

    CAS  PubMed  Google Scholar 

  • Friedman JH, Lannon MC (1990) Clozapine-responsive tremor in Parkinson’s disease. Mov Disord 5: 225–229

    CAS  PubMed  Google Scholar 

  • Ganzini L, Casey DE, Hoffman WF, McCall AL (1993) The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 153: 1469–1475

    Article  CAS  PubMed  Google Scholar 

  • García-Ruiz PJ, Mena MA, Peñfiel N, García-de-Yebenes J (1992) Parkinsonism associated with calcium channel blockers: a prospective follow up study. Clin Neuropharmacol 15: 19–26

    PubMed  Google Scholar 

  • Ghika J, Bogousslavsky J (1997) Presymptomatic hypertension is a major feature in the diagnosis of progressive supra nuclear palsy. Arch Neurol 54: 1104–1108

    CAS  PubMed  Google Scholar 

  • Goodmann JDS, Brodie C, Ayida GA (1988) Restless legs syndrome in pregnancy. Br Med 297: 1101–1102

    Google Scholar 

  • Greene P, Fahn S, Diamond B (1994) Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 9: 213–217

    Article  CAS  PubMed  Google Scholar 

  • Gunne LM, Haggstrom JE, Sjoquist B (1984) Association of persistent neuroleptic-induced dyskinesia with regional changes in the brain GABA-synthesis. Nature 309: 347–349

    Article  CAS  PubMed  Google Scholar 

  • Haussermann P, Marczoch S, Klinger C, Landgrebe M, Conrad B, Ceballos-Baumann A (2004) Long-term follow-up of cervical dystonia patients treated with botulinum toxin A. Mov Disord 19: 303–308

    Article  PubMed  Google Scholar 

  • Hoehn MM (1992) The natural history of Parkinson’s disease in the pre-levodopa eras. Neurol Clin 10: 331–340

    CAS  PubMed  Google Scholar 

  • Hughes AJ, Lees AJ, Stern GM (1991) Challenge tests to predict the dopaminergic response in untreated Parkinson’s disease. Neurology 41: 1723–1725

    CAS  PubMed  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181–184

    CAS  PubMed  Google Scholar 

  • Hughes AJ, Bishop S, Kleedorfer B et al. (1993) Subcutaneous apomorphine in Parkinson’s disease: response to chronic administration for up to five years. Mov Disord 8: 165–170

    Article  CAS  PubMed  Google Scholar 

  • Jankovic J, Orman J (1988) Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 38: 391–394

    CAS  PubMed  Google Scholar 

  • Jeste DV, Caligiuri MP (1993) Tardive dyskinesia. Schizophr Bull 19: 303–315

    CAS  PubMed  Google Scholar 

  • Kane JM, Smith JM (1982) Tardive dyskinesia. Arch Gen Psychiatry 39: 473–481

    CAS  PubMed  Google Scholar 

  • Kappler J, Menges C, Ferbert A, Ebel H (1994) Schwere »Spät«ystonie nach »Neuroleptanxiolyse« mit Fluspirilen. Nervenarzt 65: 66–68

    CAS  PubMed  Google Scholar 

  • Kessler KR, Benecke RA (1997) The edb test: a clinical test for the detection of antibodies to botulinum toxin type a. Mov Disord 12: 95–99

    Article  CAS  PubMed  Google Scholar 

  • Klinz C, Biesold K-H (1990) Familiäre paroxysmale dystone Choreoathetose. Nervenarzt 61: 507–509

    CAS  PubMed  Google Scholar 

  • Klockgether T, Jacobsen P, Löschmann PA, Turski L (1993) The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist. J Neural Transm 5: 101–106

    CAS  Google Scholar 

  • Klockgether T, Wullner U, Steinbach JP, Petersen V, Turski L, Loschmann PA (1996) Effects of the antiparkinsonian drug budipine on central neurotransmitter systems. Eur J Pharmacol 301: 67–73

    Article  CAS  PubMed  Google Scholar 

  • Koller W, Pahwa R, Busenbark K et al. (1997) High-frequency unilateral thalamic stimulation in the treatment of essenzial and parkinsonian tremor. Ann Neurol 42: 292–299

    Article  CAS  PubMed  Google Scholar 

  • Költgen D, Ceballos-Baumann AO, Franke C (1994) Botulinum toxin converts muscle acetylcholine receptors from adult to embryonic type. Muscle Nerve 17: 779–784

    Article  PubMed  Google Scholar 

  • Kornhuber J (1989) Memantine displaces (3H) MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166: 589–590

    Article  CAS  PubMed  Google Scholar 

  • Krack P, Pollak P, Limousin P et al. (1988) Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain 121: 451–457

    Google Scholar 

  • Krack P, Batir A, Van Blercom N et al. (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349: 1925–1934

    Article  CAS  PubMed  Google Scholar 

  • Krack P, Batir A, Van Blercom N et al. (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349: 1925–1934

    Article  CAS  PubMed  Google Scholar 

  • Kurth MC, Adler CH, Sthilaire M et al. (1997) Tolcapone improves motor function and reduces levodopa requirement in patients with parkinsons disease experiencing motor fluctuations: a multicenter, double blind, randomized, placebo controlled trial. Neurology 48: 81–87

    CAS  PubMed  Google Scholar 

  • Lang AE (1987) Restless legs syndrome and Parkinson’s disease: insights into pathophysiology. Clin Neuropharmacol 10: 474–478

    Google Scholar 

  • Lange DJ, Rubin M, Greene PE et al. (1991) Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes. Muscle Nerve 14: 672–675

    Article  CAS  PubMed  Google Scholar 

  • Lavigne GJ, Montplaisir JY (1994) Restless legs syndrome and sleep bruxism: Prevalence and association among Canad ians. Sleep 17: 739–743

    CAS  PubMed  Google Scholar 

  • Lazaro RP (1982) Involuntary movement disorders induced by anticonvulsant drugs. Mount Sinai J Med 49: 274–281

    CAS  Google Scholar 

  • Leube B, Rudnicki D, Ratzlaff T et al. (1996) Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a german family with adult onset, autosomal dominant inheritance and purely focal distribution. Human Molec Gen 5: 1673–1677

    CAS  Google Scholar 

  • Lew MF, Adornato BT, Duane DD et al. (1997) Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49: 701–707

    CAS  PubMed  Google Scholar 

  • Lieberman JA, Saltz BL, Johns CA et al. (1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158: 503–510

    CAS  PubMed  Google Scholar 

  • Limousin P, Pollack P, Benazzouz A et al. (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 91–95

    Google Scholar 

  • Lindvall O, Sawle G, Widner H et al. (1994) Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson’s disease. Ann Neurol 35: 172–180

    Article  CAS  PubMed  Google Scholar 

  • Litvan I, Agid Y, Calne D et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47: 1–9

    CAS  PubMed  Google Scholar 

  • Lopez OL, Wisnieski SR, Becker JT et al. (1997) Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol 54: 969–975

    CAS  PubMed  Google Scholar 

  • Lowenstein DH, Aminoff MJ (1988) The clinical course of spasmodic torticollis. Neurology 38: 530–532

    CAS  PubMed  Google Scholar 

  • Lozano AM, Lang AE, Galvez JN et al. (1995) Effect of GPi pallidotomy on motor function in Parkinson’s disease. Lancet 346: 1383–1387

    Article  CAS  PubMed  Google Scholar 

  • Marchetti A, Magar R, Findley L et al. (2005) Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study. Mov Disord

    Google Scholar 

  • Marsden CD, Jenner P (1980) The pathophysiology of extrapyra midal side-effects of neuroleptic drugs. Psychol Med 10: 55–72

    CAS  PubMed  Google Scholar 

  • Marsden CD, Quinn NP (1990) The dystonias. BMJ 300: 139–144

    CAS  PubMed  Google Scholar 

  • McKeith IG, Galasko D, Kosaka K et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113–1124

    CAS  PubMed  Google Scholar 

  • Mejia NI, Vuong KD, Jankovic J (2005) Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 20: 592–597

    PubMed  Google Scholar 

  • Montastruc JL, Rascol O, Rascol A (1989) A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: A 3 year follow-up. J Neurol Neurosurg Psychiatry 52: 773–775

    CAS  PubMed  Google Scholar 

  • Morgenstern H, Glazer WM (1993) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 50: 723–733

    CAS  PubMed  Google Scholar 

  • Moshagen V, Moschner C, Wessel K (2003) Wertigkeit neurophysiologischer Verfahren bei der Differenzialdiagnose der Systematrophien. Klin Neurophysiol 34: 55–64

    Google Scholar 

  • Nitschke MF, Kleinschmidt A, Wessel K, Frahm J (1996) Somatotopic organization of the human anterior cerebellum as detected by functional magnetic resonance neuroimaging Brain 119: 1023–1029

    PubMed  Google Scholar 

  • Nitschke MF, Hahn C, Melchert UH, Handels H, Wessel K (1998) Activation of the cerebellum by sensory finger stimulation and by finger opposition movements: A functional magnetic resonance imaging study. J Neuroimaging 8: 127–131

    CAS  PubMed  Google Scholar 

  • Nomoto M, Thompson PD, Sheehy MP et al. (1987) Anticholinergicinduced chorea in the treatment of focal dystonia. Mov Disord 2: 53–56

    CAS  PubMed  Google Scholar 

  • Nutt JG, Muenter MD, Aronson A et al. (1988) Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 3: 188–194

    Article  CAS  PubMed  Google Scholar 

  • Nygaard TG, Marsden CD, Fahn S (1991) Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology 41: 174–181

    CAS  PubMed  Google Scholar 

  • Obeso JA, Guridi J, Delong M (1997) Surgery for parkinsons disease. J Neurol Neurosurg Psychiatry 62: 2–8

    CAS  PubMed  Google Scholar 

  • Oertel W (1996) Multisystematrophie. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart New York, S. 69–77

    Google Scholar 

  • Oppenheim H (1911) Über eine eigenartige Krampfkrankheit des kindlichen und jugendlichen Alters (dysbasia lordotica progressiva, dystonia musculorum deformans). Neurologie Zentralblatt 30: 1090–1107

    Google Scholar 

  • Parkinson-Study Group (2003) A controlled trial of rotigotine monotherapy in early Parkinson’s disease. Arch Neurol 60(12): 1721–1728

    Google Scholar 

  • Pfeiffer RF, Kang J, Graber B et al. (1990) Clozapine for psychosis in Parkinson’s disease. Mov Disord 5: 239–242

    CAS  PubMed  Google Scholar 

  • Poewe WH, Lees AJ, Stern GM (1986) Low-dose L-dopa therapy in Parkinson’s disease: A 6-year follow-up study. Neurology 36: 1528–1530

    CAS  PubMed  Google Scholar 

  • Poewe W, Schelosky L, Kleedorfer B et al. (1992) Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients. J Neurol 239: 21–25

    Article  CAS  PubMed  Google Scholar 

  • Poewe W, Ceballos-Baumann AO, Conrad B (1996) Parkinson-Krankheit. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart, S 30–60

    Google Scholar 

  • Polymeropoulos MH, Higgins JJ, Golbe LI et al. (1996) Mapping of a gene for Parkinson’s disease to chromosome 4q21-q23. Science 274: 1197–1199

    Article  CAS  PubMed  Google Scholar 

  • Poulain B, Tauc L, Maisey EA, Wadsworth JD, Mohan PM, Dolly JO (1988) Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain. Proc Natl Acad Sci U S A 85: 4090–4094

    CAS  PubMed  Google Scholar 

  • Przuntek H, Bittkau S, Bliesath H et al. (2002) Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen. Arch Neurol 59: 803–806

    Article  PubMed  Google Scholar 

  • Quinn N (1994) Multiple system atrophy. In: Marsden CD, Fahn S (eds) Movement disorders 3. Butterworth Heinemann, Oxford, pp 263–281

    Google Scholar 

  • Quinn NP (1996) Review: essenzial myoclonus and myoclonic dystonia. Mov Disord 11: 119–126

    Article  CAS  PubMed  Google Scholar 

  • Raja M (1995) Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric patients. Eur Arch Psych Clin Neurosci 145–151

    Google Scholar 

  • Rebeiz JJ, Kolodny EH, Richardson EP (1968) Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20–33

    CAS  PubMed  Google Scholar 

  • report NioHC (1991) Clinical use of botulinum toxin. National Insti tutes of Health consensus development. Arch Neurol 48: 1294–1298

    Google Scholar 

  • Riley D, Lang AE, Blair RDG et al. (1988) Frozen shoulder and other shoulder abnormalities in Parkinson’s disease. J Neurol Neurosurg Psychiatry 52: 63–66

    Google Scholar 

  • Rinne UK (1989) Lisuride, a dopamine agonist in the treatment of early Parkinson’s disease. Neurology 39: 336–339

    CAS  PubMed  Google Scholar 

  • Rinne UK, Bracco F, Chouza C et al. (1997) Cabergoline in the treatment of early parkinsons disease: results of the first year of treatment in a double blind comparison of cabergoline and levodopa. Neurology 48: 363–368

    CAS  PubMed  Google Scholar 

  • Rinne UK, Larsen JP, Siden A, Worm-Petersen J (1998) Enta capone enhances the response to levodopa in parkinsonian patients with motor fluctruations. Nomecomt Study Group. Neurology 51: 1309–1314

    CAS  PubMed  Google Scholar 

  • Roggenkamper P, Jost WH, Bihari K, Comes G, Grafe S (2005) Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm

    Google Scholar 

  • Rothdach A, Trenkwalder C, Haberstock J et al. (2000) Prevalence and risk factors of RLS in an elderly population: The MEMO study. Neurology 54: 1064–1068

    CAS  PubMed  Google Scholar 

  • Saint HM, Burke RE, Bressman SB et al. (1991) Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology 41: 216–222

    Google Scholar 

  • Salih AM, Gray RES, Mills KR, Webley M (1994) A clinical, serological and neurophysiological study of restless-legs syndrome in rheumatoid arthritis. Br J Rheumatol 33: 60–63

    CAS  PubMed  Google Scholar 

  • Saudou F, Finkbeiner S, Devys D, Greenberg M (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55–66

    Article  CAS  PubMed  Google Scholar 

  • Schanz EJ, Johnson EA (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 1992: 80–99

    Google Scholar 

  • Schrag A, Ben-Shlomo Y, Quinn N (2002) How common are complications of Parkinson’s disease? J Neurol 249: 419–423

    Article  PubMed  Google Scholar 

  • Schwarz M, Noth J (1999) Chorea und Ballismus. In: Hopf HC, Deuschl G, Diener HC, Reichmann H (Hrsg) Neurologie in Klinik und Praxis, Thieme, Stuttgart New York, S 78–86

    Google Scholar 

  • Schwarz J, Tatsch K, Arnold G (1992) 123-Iodobenyamide-SPECT predicts dopaminergic responsiveness in patients with »de novo« Parkinsonism. Neurology 42: 556–561

    CAS  PubMed  Google Scholar 

  • Sheehy MP, Marsden CD (1982) Writers’ cramp-a focal dystonia. Brain 105: 461–481

    PubMed  Google Scholar 

  • Siatkowski RM, Tyutyunikov A, Biglan AW et al. (1993) Serum antibody production to botulinum A toxin. Ophthalmology 100: 1861–1866

    CAS  PubMed  Google Scholar 

  • Siegfried J, Lippitz B (1994) Bilateral chronic electrostimula tion of ventroposterolateral pallidum: a new therapeutic approach for alleviat ing all parkinsonian symptoms. Neurosurgery 35: 1126–1129

    CAS  PubMed  Google Scholar 

  • Spieker S, Loschmann PA, Klockgether T (1999) The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations. Mov Disord 14: 517–519

    Article  CAS  PubMed  Google Scholar 

  • Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10: 333–358

    CAS  PubMed  Google Scholar 

  • Steele J, Faulds D, Sorkin EM (1993) Tiapride: A review of its pharmacodynamic properties and therpeutic potenzial in geriatric population. Drugs & Aging 3: 460–478

    CAS  Google Scholar 

  • Stein MB, Heuser IJ, Juncos JL, Uhde TW (1990) Anxiety dis orders in patients with Parkinson’s disease. Am J Psychiatry 147: 217–220

    CAS  PubMed  Google Scholar 

  • Sweet C (1975) Drug induced dystonia. Am J Psychiatry 132: 532–533

    Google Scholar 

  • Tanaka M, Hirai S, Kondo S et al. (1998) Cerebral hypoperfusion and hypometabolism with altered striatal signal intensity in choreaacanthocytosis: a combined PET and MRI study. Mov Disord 13: 100–107

    Article  CAS  PubMed  Google Scholar 

  • Tanner CM (1994) Epidemiological clues to the cause of Parkinson’s disease. In: Marsden CD (eds) Movement dis orders 3. Butterworths London, pp 124–146

    Google Scholar 

  • Taylor TD, Litt M, Kramer P et al. (1996) Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3–p13 [published erratum appears in Nat Genet 1997 May;16(1):109]. Nat Genet 14: 479–481

    Article  CAS  PubMed  Google Scholar 

  • The Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson’s disease. N Engl J Med 340: 757–763

    Article  Google Scholar 

  • Trenkwalder C, Stiasny K, Oertel WH (1996) Therapie des idiopathischen und urämischen Restless-legs-Syndroms. Nervenarzt 67: 265–276

    CAS  PubMed  Google Scholar 

  • Trosch RM, Friedman JH, Lannon MC et al. (1998) Clozapine use in Parkinson’s disease: a retrospective ana lysis of a large multicentered clinical experience. Mov Disord 13: 377–382

    Article  CAS  PubMed  Google Scholar 

  • Tyne HL, Parsons J, Sinnott A, Fox SH, Fletcher NA, Steiger MJ (2004) A 10 year retrospective audit of long-term apomorphine use in Parkinson’s disease. J Neurol 251: 1370–1374

    Article  PubMed  Google Scholar 

  • Verhagen Metman L, Del Dotto P, van den Munckhof P et al. (1998) Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson’s disease. Neurology 50: 1323–1326

    Google Scholar 

  • Vidailhet M, Vercueil L, Houeto JL et al. (2005) Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med 352: 459–467

    Article  CAS  PubMed  Google Scholar 

  • Waddy HM, Fletcher NA, Harding AE, Marsden CD (1991) A genetic study of idiopathic focal dystonias. Ann Neurol 29: 320–324

    Article  CAS  PubMed  Google Scholar 

  • Walshe JM, Yealland M (1992) Wilson’s disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiatry 55: 692–696

    CAS  PubMed  Google Scholar 

  • Walters AS, Picchietti D, Hening WA, Lazzarini A (1990) Variable expression in familial restless legs syndrome. Ann Neurol 47: 1219–1220

    CAS  Google Scholar 

  • Walters AS and the International Restless-legs-Syndrome Study Group (1995) Towards a better definition of the restless legs syndrome. Mov Disord 10: 634–642

    Google Scholar 

  • Walters AS, Hickey K, Maltzman J et al. (1996) A questionnaire study of 138 patients with restless legs syndrome: The »Night-Walkers« survey. Neurology 46: 92–95

    CAS  PubMed  Google Scholar 

  • Wenning GK, Pramstaller PP, Ransmayr G, Poewe W (1997) Atypische Parkinson-Syndrome. Nervenarzt 68: 102–115

    Article  CAS  PubMed  Google Scholar 

  • Wessel K, Diener HC, Dichgans J, Thron A (1988) Cerebellar dysfunction in patients with bronchogenic carcinoma: clinical and posturographic findings. J Neurol 235: 290–296

    CAS  PubMed  Google Scholar 

  • Wessel K, Schroth G, Diener HC et al. (1989) Significance of MRI-confirmed atrophy of the cranial spinal cord in Fried reich’s ataxia. Eur Arch Psychiatr Neurol Sci 238: 225–230

    CAS  Google Scholar 

  • Wessel K (2003) Transcranial magnetic brain stimulation and the cerebellum. Transcranial magnetic stimulation and transcranial direct current stimulation. Clin Neuophysiol (Suppl.) 56: 441–445

    CAS  Google Scholar 

  • Wessel K, Verleger R, Nazarenus D, Vieregge P, Kömpf D (1994) Movement-related cortical potenzials preceding sequenzial and goaldirected finger movements in patients with cerebellar atrophy. Electroenceph Clin Neurophysiol 92: 331–341

    Article  CAS  PubMed  Google Scholar 

  • Wessel K, Hermsdörfer J, Deger K et al. (1995a) Double-blind cross over study with L-5-hydroxy tryptophane in patients with degenerative cerebellar diseases. Arch Neurol 52: 451–455

    CAS  PubMed  Google Scholar 

  • Wessel K, Zeffiro T, Lou JS, Toro C, Hallet M (1995b) Regional cerebral blood flow during a self-paced sequenzial finger opposition task in patients with cerebellar degeneration. Brain 118: 379–393

    PubMed  Google Scholar 

  • Wessel K, Tegenthoff M, Vorgerd M et al. (1996) Enhanced inhibitory mechanisms in the motor cortex of patients with cerebellar degeneration: A study with transcranial magnetic brain stimulation. Electroenceph clin Neurophysiol 101: 273–281

    CAS  PubMed  Google Scholar 

  • Wissel J, Kabus C, Wenzel R et al. (1996) Botulinum toxin in writers cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 61: 172–175

    CAS  PubMed  Google Scholar 

  • Wolf SS, Jones DW, Knable MB et al. (1996) Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273: 1225–1227

    CAS  PubMed  Google Scholar 

  • Zimprich A, Grabowski M, Asmus F et al. (2001) Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29: 66–69

    Article  CAS  PubMed  Google Scholar 

Weiterführende Literatur

  • Albin RL, Young AB, Penney JB (1989) The functional anatomy of disorders of the basal ganglia disorders. Trends Neurosc 12: 366–375

    CAS  Google Scholar 

  • Alesch F, Pinter MM, Helscher RJ et al. (1995) Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson’s disease and essenzial tremor. Acta Neurochir Wien 136: 75–81

    Article  CAS  PubMed  Google Scholar 

  • Arendt G, Hefter H, Stremmel W, Strohmeyer G (1994) The diagnostic value of multi-modality evoked potenzials in Wilson’ s disease. Electromyogr Clin Neurophysiol 34: 137–148

    CAS  PubMed  Google Scholar 

  • Bain PG (1993) A combined clinical and neurophysiological approach to the study of patients with tremor. J Neurol Neurosurg Psychiatry 69: 839–844

    Google Scholar 

  • Bhatia KP, Brown P, Gregory R et al. (1995) Progressive myo clonic ataxia associated with coeliac disease. Brain 118: 1087–1093

    PubMed  Google Scholar 

  • Boecker H, Wills A, Ceballos-Baumann AO et al. (1996) The functional effect of ethanol on alcohol-responsive essenzial tremor. Ann Neurol 39: 650–658

    Article  CAS  PubMed  Google Scholar 

  • Bonelli RM, Wenning GK, Kapfhammer HP (2004) Huntington’s disease: present treatments and future therapeutic modalities. Int Clin Psychophamacol 19: 51–62

    Google Scholar 

  • Braune S, Reinhardt M, Schnitzer R et al. (1999) Cardiac uptake of [123J]MIBG separates Parkinson’s disease from multiple system atrophy. Neurology 53: 1020–1025

    CAS  PubMed  Google Scholar 

  • Breedveld GJ, Percy AK, MacDonald ME et al. (2002) Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 59: 579–584

    CAS  PubMed  Google Scholar 

  • Brewer GJ, Yuzbasian-Gurkan V (1992) Wilson’s disease. Medicine 71: 139–164

    CAS  PubMed  Google Scholar 

  • Brewer GJ, Johnson V, Dick RD (1996) Treatment of Wilson disease with ammonium tetrathiomolyb-date. Arch Neurol 53: 1017–1025

    CAS  PubMed  Google Scholar 

  • Brewer GJ, Hedera P, Kluin KJ et al. (2003) Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60: 379–385

    Article  PubMed  Google Scholar 

  • Bruyn GW, Went LN (1986) Huntington’s chorea. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of Clinical Neurology, vol 49, Elsevier, Amsterdam New York, pp 267–314

    Google Scholar 

  • Bürk K, Abele M, Fetter M et al. (1996) Autosomal dominant cerebellar ataxia typ I. Clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain 119: 1497–1505

    PubMed  Google Scholar 

  • Ceballos-Baumann AO (1995) Medikamentös induzierte Dyskinesien. Akt Neurol 22: 245–257

    Google Scholar 

  • Ceballos-Baumann AO (1996a) Dystonien. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart, S 89–140

    Google Scholar 

  • Ceballos-Baumann AO (1996b) Medikamentös induzierte Bewegungsstörungen. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart, S 308–332

    Google Scholar 

  • Ceballos-Baumann AO, Conrad B (1994a) Essenzieller Tremor. Münch Med Wochenschr 136: 196–198

    Google Scholar 

  • Ceballos-Baumann AO, Conrad B (1994b) Tourette-Syndrom und Tic-Störungen. Münch Med Wschr 136: 277–280

    Google Scholar 

  • Cha JH (2000) Transcriptional dysregulation in Huntington’s disease. Trends Neurosci 23: 387–392

    Article  CAS  PubMed  Google Scholar 

  • Church AJ, Dale RC, Cardoso F et al. (2003) CSF and serum immune parameters in Sydenham’s chorea: evidence of an autoimmune syndrome? J Neuroimmunol 136: 148–153

    Article  Google Scholar 

  • Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ (1995) Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson’s disease. Arch Neurol 52: 294–298

    CAS  PubMed  Google Scholar 

  • Conrad B (1996) Tics/Tourette-Syndrom. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart New York, S 186–221

    Google Scholar 

  • Conrad B (2005) Wilson-Krankheit. In: Ceballos-Baumann AO, Conrad B (Hrsg) Bewegungsstörungen in der Neurologie. Thieme, Stuttgart New York, S 181–194

    Google Scholar 

  • Danek A (1998) Restless-legs-Syndrom. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 3. Aufl. Kohlhammer, Stuttgart Berlin Köln, S 935–940

    Google Scholar 

  • Danek A (2002) Fortschritte in der molekularen Choreadiagnostik: McLeod-Syndrom und Chorea-Akanthozytose. Nervenarzt 73: 564–569

    Article  CAS  PubMed  Google Scholar 

  • Diener HC, Dichgans J, Bacher M, Guschlbauer B (1984) Improvement of ataxia in alcoholic cerebellar atrophy through alcohol abstinence. J Neurol 231: 258–262

    Article  CAS  PubMed  Google Scholar 

  • Fahn S (1994) The paroxysmal dyskinesias. In Marsden CD, Fahn S (eds) Movement Disorders 3. Butterworth-Heinemann, Oxford, 310–345

    Google Scholar 

  • Fahn S, Bressman S, Marsden CD (to be published) Classification of dystonia. Adv Neurol

    Google Scholar 

  • Geissler I, Heinemann K, Rohm S, Hauss J, Lamesch P (2003) Liver transplantation for hepatic and neurological Wilsons disease. Transplant Proc 35: 1445–1446

    Article  CAS  PubMed  Google Scholar 

  • Gilman S et al. (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163: 94–98

    Article  CAS  PubMed  Google Scholar 

  • Hardie RJ, Pullon HWH, Harding AE et al. (1991) Neuroacan thocytosis. A clinical, haematological and pathological study of 19 cases. Brain 114: 13–49

    PubMed  Google Scholar 

  • Harding A (1995) Inherited ataxias. Curr Opin Neurol 8: 306–309

    CAS  PubMed  Google Scholar 

  • Huntington Study Group (2001) A randomised, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology 57: 397–404

    Google Scholar 

  • Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72: 971–983

    Google Scholar 

  • Khoshnan A, Ko J, Patterson PH (2002) Effects of intracellular expression of antihuntington antibodies of various specificities on mutant Huntington aggregation and toxicity. Proc Natl Acad Sci USA 99: 1002–1007

    Article  CAS  PubMed  Google Scholar 

  • Kimber JR, Watson L, Mathias CJ (1997) Distinction of idiopathic Parkinson’s disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet 349: 1877–1881

    Article  CAS  PubMed  Google Scholar 

  • Klockgether T, Döller G, Wüllner U, Petersen D, Dichgans J (1993) Cerebellar encephalitis in adults. J Neurol 240: 17–20

    Article  CAS  PubMed  Google Scholar 

  • Klockgether T, Wüllner U, Dichgans J et al. (1993) Clinical and imaging correlations in inherited ataxias. Adv Neurol 61: 77–96

    CAS  PubMed  Google Scholar 

  • Lajonchere C, Nortz M, Finger S (1996) Gilles de la Tourette and the discovery of Tourette syndrome. Arch Neurol: 567–574

    Google Scholar 

  • Lang AE (1994) Withdrawal akathisia: case reports and a proposed classification of chronic akathisia. Mov Disord 9: 188–192

    Article  CAS  PubMed  Google Scholar 

  • Lees AJ (1985) Tics and related disorders. Churchill Living stone, Edinburgh

    Google Scholar 

  • Menkes JH (1995) Disorders of mental metabolism. In: Rowland LP (ed) Merrits’s Textbook of Neurology. Williams & Wilkins, Baltimore, pp 584–589

    Google Scholar 

  • Müller N, Putz A, Straube A, Kathmann N (1995) Zwangsstörung und das Gilles-de-la-Tourette-Syndrom. Über die Differenzialdiagnose von organischen und psychogenen Symptomen. Nervenarzt 66: 372–378

    PubMed  Google Scholar 

  • Padberg G, Bruyn GW (1986) Chorea: differential diagnosis. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of Clinical Neurology, vol 49. Elsevier, Amsterdam New York, pp 549–555

    Google Scholar 

  • Ranen NG, Stine OC, Abbott MH et al. (1995) Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington Disease. Am J Hum Genet 57: 593–602

    CAS  PubMed  Google Scholar 

  • Rosenberg RN (1995) Autosomal dominant cerebellar phenotypes. The genotype has settled the issue. Neurology 45: 1–5

    CAS  PubMed  Google Scholar 

  • Ross (2004) Huntington’s disease: a new paths to pathogenesis. Cell 118: 4–7

    Article  CAS  PubMed  Google Scholar 

  • Sambrook MA, Crossmann AR, Mitchell IJ (1994) Experimental models of basal ganglia disease. Mov Disord 3: 28–45

    Google Scholar 

  • Schmidt HH-J (2003) Diagnostik und Therapie des Morbus Wilson. Dtsch Ärztebl 100: A192–197

    Google Scholar 

  • Sharp AH, Ross CA (1996) Neurobiology of Huntington’s disease. Neurobiol Disease 3: 3–15

    CAS  Google Scholar 

  • Stracciari A, Tempestini A, Borghi A, Guarino M (2000) Effect of liver transplantation on neurological manifestations in Wilson disease. Arch Neurol 57: 384–386

    Article  CAS  PubMed  Google Scholar 

  • Tanzi RE, Petrukhin K, Chernov I (1993) The Wilson’s disease gene is a copper-transporting ATPase with homology to the Menkes disease gene. Nature Genet 5: 344–350

    Article  CAS  PubMed  Google Scholar 

  • Walshe JM (1986) Wilson’s disease. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of Clinical Neurology, vol 49. Elsevier, Amsterdam New York, pp 549–555

    Google Scholar 

  • Watanabe H, Saito Y, Terao S (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125: 1070–1083

    Article  PubMed  Google Scholar 

  • Weiland T, Wessel K (2005) Ataxien. Fortschr Neurol Psychiatr 73: 286–299

    Article  CAS  PubMed  Google Scholar 

  • Weindl A, Conrad B (1996) Chorea und choreatische Bewegungsstörungen. In: Conrad B, Ceballos-Baumann AO (Hrsg) Bewegungsstörungen in der Neurologie, Thieme, Stuttgart New York, S 155–180

    Google Scholar 

  • Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP (1997) Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 12: 133–147

    CAS  PubMed  Google Scholar 

  • Wenning GK, Colosimo C, Geser F et al. (2004) Multiple system atrophy. Lancet Neurol 3: 93–103

    PubMed  Google Scholar 

  • Wessel K, Kömpf D (1988) Paraneoplastic cerebellar degeneration in patients with bronchogenic carcinoma. Prog Clin Neurosci 2: 43–55

    Google Scholar 

  • Wessel K, Huss HP, Brückmann H, Kömpf D (1993) Follow-up of neurophysiological tests and CT in late-onset cerebellar ataxia and multiple system atrophy. J Neurol 240: 168–176

    CAS  PubMed  Google Scholar 

  • Wessel K, Moschner C, Wandinger KP, Kömpf D, Heide W (1998) Oculomotor testing in the differential diagnosis of degenerative ataxic disorders. Arch Neurol 55: 949–956

    Article  CAS  PubMed  Google Scholar 

  • Winkelmann MD, Hines JD (1983) Cerebellar degeneration caused by high-dose cytosine arabinoside: A clinicopa thological study. Ann Neurol 14: 520–527

    Google Scholar 

  • Wittkämper A, Wessel K, Brückmann H, Kömpf D (1993) CT-morphology in patients with autosomal dominant or idiopathic cerebellar ataxia. Neuroradiology 35: 520–524

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologisches Krankenhaus, Tristanstr. 20, 80804, München

    A. O. Ceballos-Baumann (Prof. Dr.)

  2. Neurologische Klinik, Städtische Kliniken Dortmund, Beurhausstr. 40, 44137, Dortmund

    M. Schwarz (Prof. Dr.)

  3. Neurologische Klinik, Städitsches Klinikum, und Forschungsgesellschaft für Kognitive Neurologie, Institut an der TU Braunschweig, Salzdahlumer Str. 90, 38126, Braunschweig

    K. Wessel (Prof. Dr.)

  4. Neurologische Abteilung, St. Lukas Klinik, Schwanenstr. 132, 42697, Solingen

    S. Meyring (Dr.)

Authors
  1. A. O. Ceballos-Baumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Wessel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Meyring
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Alfried Krupp Krankenhaus, Alfried-Krupp-Str. 21, 45131, Essen

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Ceballos-Baumann, A.O., Schwarz, M., Wessel, K., Meyring, S. (2006). Bewegungsstörungen. In: Berlit, P. (eds) Klinische Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31176-9_39

Download citation

  • DOI: https://doi.org/10.1007/3-540-31176-9_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-01982-4

  • Online ISBN: 978-3-540-31176-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation